TY - JOUR
T1 - Neural precursor cell-secreted TGF-β2 redirects inflammatory monocyte-derived cells in CNS autoimmunity.
AU - Feo, Donatella De
AU - Merlini, Arianna
AU - Brambilla, Elena
AU - Ottoboni, Linda
AU - Laterza, Cecilia
AU - Menon, Ramesh
AU - Srinivasan, Sundararajan
AU - Farina, Cinthia
AU - Manteiga, Jose Manuel Garcia
AU - Butti, Erica
AU - Bacigaluppi, Marco
AU - Comi, Giancarlo
AU - Greter, Melanie
AU - Martino, Gianvito
N1 - Funding Information:
We thank the Center for Translational Genomics and BioInfor-matics, San Raffaele Scientific Institute, for RNA sequencing and bioinformatics analysis; Advanced Light and Electron Microscopy BioImaging Center, San Raffaele Scientific Institute, for the use of equipment; the Center for Microscopy and Image Analysis, University of Zürich, for the use of equipment; the Mouse HistoPathology Unit, San Raffaele Scientific Institute, for support and equipment usage for immunohistochemistry; F. Ruffini and A. Finardi, San Raffaele Scientific Institute, for technical assistance; Thomas Doetschman, University of Arizona, for providing the Tgfb2-knockout strain; V. Tosevski, University of Zürich, for technical help and FACS sorting; and A. Cantore, TIGET San Raffaele Scientific Institute, for Tgfb2-expressing lentiviral vector production. This work has been in part supported by TargetBrain (EU Frame-work 7 project HEALTH-F2-2012–279017), by NEUROKINE network (EU Framework 7 ITN project), by BMW Italy Group, by Fondazione Italiana Sclerosi Multipla (FISM) n the project entitled Progetto Speciale Cellule Staminali, and by CARIPLO Foundation grant no. 2010 1835 to GM and by Ministero della Salute Italiana (Progetto Giovani Ricercatori 58/GR-2011-02348160) to MB.
PY - 2017/9/25
Y1 - 2017/9/25
N2 - In multiple sclerosis, the pathological interaction between autoreactive Th cells and mononuclear phagocytes in the CNS drives initiation and maintenance of chronic neuroinflammation. Here, we found that intrathecal transplantation of neural stem/precursor cells (NPCs) in mice with experimental autoimmune encephalomyelitis (EAE) impairs the accumulation of inflammatory monocyte-derived cells (MCs) in the CNS, leading to improved clinical outcome. Secretion of IL-23, IL-1, and TNF-α, the cytokines required for terminal differentiation of Th cells, decreased in the CNS of NPC-treated mice, consequently inhibiting the induction of GM-CSF-producing pathogenic Th cells. In vivo and in vitro transcriptome analyses showed that NPC-secreted factors inhibit MC differentiation and activation, favoring the switch toward an antiinflammatory phenotype. Tgfb2-/- NPCs transplanted into EAE mice were ineffective in impairing MC accumulation within the CNS and failed to drive clinical improvement. Moreover, intrathecal delivery of TGF-β2 during the effector phase of EAE ameliorated disease severity. Taken together, these observations identify TGF-β2 as the crucial mediator of NPC immunomodulation. This study provides evidence that intrathecally transplanted NPCs interfere with the CNS-restricted inflammation of EAE by reprogramming infiltrating MCs into antiinflammatory myeloid cells via secretion of TGF-β2.
AB - In multiple sclerosis, the pathological interaction between autoreactive Th cells and mononuclear phagocytes in the CNS drives initiation and maintenance of chronic neuroinflammation. Here, we found that intrathecal transplantation of neural stem/precursor cells (NPCs) in mice with experimental autoimmune encephalomyelitis (EAE) impairs the accumulation of inflammatory monocyte-derived cells (MCs) in the CNS, leading to improved clinical outcome. Secretion of IL-23, IL-1, and TNF-α, the cytokines required for terminal differentiation of Th cells, decreased in the CNS of NPC-treated mice, consequently inhibiting the induction of GM-CSF-producing pathogenic Th cells. In vivo and in vitro transcriptome analyses showed that NPC-secreted factors inhibit MC differentiation and activation, favoring the switch toward an antiinflammatory phenotype. Tgfb2-/- NPCs transplanted into EAE mice were ineffective in impairing MC accumulation within the CNS and failed to drive clinical improvement. Moreover, intrathecal delivery of TGF-β2 during the effector phase of EAE ameliorated disease severity. Taken together, these observations identify TGF-β2 as the crucial mediator of NPC immunomodulation. This study provides evidence that intrathecally transplanted NPCs interfere with the CNS-restricted inflammation of EAE by reprogramming infiltrating MCs into antiinflammatory myeloid cells via secretion of TGF-β2.
UR - https://www.scopus.com/pages/publications/85032988069
U2 - 10.1172/JCI92387
DO - 10.1172/JCI92387
M3 - Article
C2 - 28945200
AN - SCOPUS:85032988069
SN - 0021-9738
VL - 127
SP - 3937
EP - 3953
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 11
ER -